13FINSTITUTION · CIK 0001493215 · 2026-Q3 · Filed Nov 16, 2026
Rtw Investments
RTW INVESTMENTS, LP
$9.9B
13F long value · 2026-Q3 Positions83
CategoryAsset manager
Quarters tracked10
●#466 of 556 by 13F long value
Size rank 2/10
6NEW6ADD12×+5TRIM3NEAR EXIT5EXIT
Snapshot
Rtw Investments's 13F portfolio at a glance: size, concentration and this quarter's activity.
13F long value
$9.9B
Positions
83
Top 83 long weight
99.8%
Quarters tracked
10
Latest 13F filed
Nov 16, 2026
New positions
6
Exits / near-exits
8
13F long value by quarter
Reported long equity value each quarter: fund flows plus market moves. Option notional is not included.
Top holdings · 2026-Q3
The fund's largest reported positions. The long positions shown cover 99.8% of the long value.
| Ticker | Issuer | Weight | Value | Shares | Since 2026-Q3 |
|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics, Inc | Protagonist Therapeutics, Inc | 7.2% | $713.1M | 5.1M | -11.4% |
| ARGX ARGENX SE | ARGENX SE | 6.9% | $682.3M | 711.6K | -0.8% |
| CGON CG Oncology, Inc. | CG Oncology, Inc. | 6.1% | $603.6M | 8.5M | +19.6% |
| IRTC iRhythm Holdings, Inc. | iRhythm Holdings, Inc. | 3.6% | $354.5M | 3.1M | -20.1% |
| INSM INSMED Inc | INSMED Inc | 3.6% | $353.4M | 3.1M | +7.7% |
| TNGX Tango Therapeutics, Inc. | Tango Therapeutics, Inc. | 3.5% | $350.5M | 14.0M | -3.1% |
| ERAS Erasca, Inc. | Erasca, Inc. | 3.3% | $329.1M | 22.4M | +3.1% |
| SYRE Spyre Therapeutics, Inc. | Spyre Therapeutics, Inc. | 3.3% | $328.7M | 3.7M | +11.6% |
| RDNT RadNet, Inc. | RadNet, Inc. | 3.2% | $319.2M | 4.6M | +11.5% |
| TARS Tarsus Pharmaceuticals, Inc. | Tarsus Pharmaceuticals, Inc. | 2.8% | $273.9M | 3.5M | +0.1% |
| ZLAB Zai Lab Ltd | Zai Lab Ltd | 2.7% | $272.6M | 10.4M | -10.9% |
| RGEN REPLIGEN CORP | REPLIGEN CORP | 2.7% | $266.3M | 1.4M | -15.3% |
| GH Guardant Health, Inc. | Guardant Health, Inc. | 2.7% | $264.2M | 1.5M | -19.2% |
| CELC Celcuity Inc. | Celcuity Inc. | 2.6% | $262.8M | 3.3M | -23.8% |
| ORKA Oruka Therapeutics, Inc. | Oruka Therapeutics, Inc. | 2.6% | $261.4M | 3.1M | +19.1% |
Quarterly changes · 2026-Q3
What Rtw Investments opened, added, trimmed and exited this quarter, largest dollar moves first.
| Action | Ticker | Issuer | Prev shares | Curr shares | Change | Value Δ |
|---|---|---|---|---|---|---|
| NEAR EXIT | MDGL NEAR EXIT MADRIGAL PHARMACEUTICALS, INC. | MADRIGAL PHARMACEUTICALS, INC. | 2.0M | 312.8K | -84.3% | -$912.9M |
| NEAR EXIT | PTCT NEAR EXIT PTC THERAPEUTICS, INC. | PTC THERAPEUTICS, INC. | 7.7M | 1.6M | -79.1% | -$527.2M |
| TRIM | INSM TRIM INSMED Inc | INSMED Inc | 4.8M | 3.1M | -36.1% | -$162.9M |
| ADD | ZLAB ADD Zai Lab Ltd | Zai Lab Ltd | 6.6M | 10.4M | +57.5% | +$147.7M |
| NEW | VRDN NEW Viridian Therapeutics, Inc.\DE | Viridian Therapeutics, Inc.\DE | 0 | 4.9M | New | +$101.1M |
| ADD | IRTC ADD iRhythm Holdings, Inc. | iRhythm Holdings, Inc. | 2.2M | 3.1M | +42.9% | +$94.9M |
| EXIT | ALKS EXIT Alkermes plc. | Alkermes plc. | 1.7M | 0 | -100.0% | -$87.6M |
| TRIM | NBIX TRIM NEUROCRINE BIOSCIENCES INC | NEUROCRINE BIOSCIENCES INC | 1.3M | 942.7K | -25.7% | -$80.0M |
| TRIM | CADL TRIM Candel Therapeutics, Inc. | Candel Therapeutics, Inc. | 6.4M | 3.2M | -50.0% | -$32.6M |
| NEW | KRSA NEW Korsana Biosciences, Inc. | Korsana Biosciences, Inc. | 0 | 877.0K | New | +$28.1M |
Conviction over time
Portfolio weight of the current top long holdings, quarter by quarter; rising weight = growing conviction.